{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:27:34Z","timestamp":1770366454782,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    This study aimed to investigate the usefulness of interim\n                    <jats:sup>18<\/jats:sup>\n                    F fluorodeoxyglucose positron emission tomography\u2013computed tomography (FDG PET\/CT) during definitive radiation therapy (RT) as a prognostic indicator of disease recurrence in patients with hypopharyngeal squamous cell carcinoma. This prospective analysis included 35 patients with biopsy-proven hypopharyngeal squamous cell carcinoma who received platinum-based chemoradiotherapy and underwent pretreatment FDG PET\/CT and interim FDG PET\/CT (iPET) at a cumulative RT doses of 36.0\u201345.0 Gy. The maximum standardized uptake value (SUVmax), metabolic tumor volume, and total lesion glycolysis of the primary tumor (PT) and combined total lymph nodes for both pre-PET and iPET were analyzed, and their percentage reductions in iPET were calculated. The optimal cutoff values of the metabolic parameters were derived from receiver operating characteristic curves. The outcomes were compared between patients with metabolic parameters above and below the respective cutoff values. Disease recurrence (locoregional or distant) was defined as a biopsy-proven tumor or unequivocal clinical and radiological evidence of progression. Twelve (34%) patients experienced disease recurrence during a median follow-up of 52 months. Univariate Cox regression analysis revealed that the reduction ratio of the SUVmax of the PT (\u0394SUVp; hazard ratio, 7.685; p\u2009=\u20090.008) was a significant predictor of disease recurrence. Kaplan\u2013Meier curve analysis revealed that a smaller \u0394SUVp was associated with worse progression-free survival (log-rank, p\u2009=\u20090.002). Metabolic parameters measured using iPET may be useful predictors of disease recurrence in patients with hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. In this study, \u0394SUVp was the best prognostic indicator.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0341189","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:23:29Z","timestamp":1770315809000},"page":"e0341189","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic role of interim F-18 fluorodeoxyglucose positron emission tomography-computed tomography during chemoradiation therapy in patients with hypopharyngeal squamous cell carcinoma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1947-1644","authenticated-orcid":true,"given":"Takamitsu","family":"Mase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Toyomasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ishinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Nanpei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-3738","authenticated-orcid":true,"given":"Noriko","family":"Ii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5521-9324","authenticated-orcid":true,"given":"Yoshihito","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"3","key":"pone.0341189.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"30","key":"pone.0341189.ref002","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2025.40.e177","article-title":"Global, regional, and national burden of pharyngeal cancer and projections to 2050 in 185 countries: a population-based systematic analysis of GLOBOCAN 2022","volume":"40","author":"W Jang","year":"2025","journal-title":"J Korean Med Sci"},{"issue":"13","key":"pone.0341189.ref003","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.3390\/jcm13133853","article-title":"Influencing factors of survival in hypopharyngeal squamous cell cancer","volume":"13","author":"GD R\u00e9p\u00e1ssy","year":"2024","journal-title":"J Clin Med"},{"issue":"9208","key":"pone.0341189.ref004","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data","volume":"355","author":"J Pignon","year":"2000","journal-title":"The Lancet"},{"issue":"4","key":"pone.0341189.ref005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ijrobp.2012.03.005","article-title":"Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis","volume":"84","author":"M Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"pone.0341189.ref006","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3390\/cancers16101905","article-title":"Role of 18F-FDG PET\/CT in head and neck squamous cell carcinoma: current evidence and innovative applications","volume":"16","author":"C Caldarella","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"22","key":"pone.0341189.ref007","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.3390\/cancers15225461","article-title":"The diagnostic and predictive value of 18F-Fluorodeoxyglucose positron emission tomography\/computed tomography in laryngeal squamous cell carcinoma","volume":"15","author":"A Al-Ibraheem","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10","key":"pone.0341189.ref008","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.3390\/jcm12103514","article-title":"The prognostic and diagnostic value of [18F]FDG PET\/CT in untreated laryngeal carcinoma","volume":"12","author":"A Al-Ibraheem","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0341189.ref009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis","volume":"55","author":"K Pak","year":"2014","journal-title":"J Nucl Med"},{"issue":"9","key":"pone.0341189.ref010","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00259-015-3051-4","article-title":"Prognostic significance of standardized uptake value and metabolic tumour volume on \u00b9\u2078F-FDG PET\/CT in oropharyngeal squamous cell carcinoma","volume":"42","author":"JW Kim","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"pone.0341189.ref011","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12094-017-1674-6","article-title":"Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET\/CT in locally advanced head and neck squamous cell carcinoma","volume":"19","author":"J Cacicedo","year":"2017","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"pone.0341189.ref012","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1007\/s00259-018-4065-5","article-title":"What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis","volume":"45","author":"P Bonomo","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"pone.0341189.ref013","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MNM.0000000000000974","article-title":"Prognostic value of 18F-FDG PET\/CT functional parameters in patients with head and neck cancer","volume":"40","author":"L Wang","year":"2019","journal-title":"Nuclear Med Commun"},{"issue":"12","key":"pone.0341189.ref014","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/lary.24826","article-title":"Interim FDG PET\/CT for predicting the outcome in patients with head and neck cancer","volume":"124","author":"S-W Chen","year":"2014","journal-title":"Laryngoscope"},{"issue":"10","key":"pone.0341189.ref015","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/hed.24454","article-title":"Prognostic value of midtreatment FDG-PET in oropharyngeal cancer","volume":"38","author":"EL Pollom","year":"2016","journal-title":"Head Neck"},{"issue":"3","key":"pone.0341189.ref016","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijrobp.2017.02.217","article-title":"Interim 18F-FDG PET\/CT during chemoradiation therapy in the management of head and neck cancer patients: a systematic review","volume":"98","author":"C Garibaldi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"pone.0341189.ref017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3857\/roj.2017.00577","article-title":"Prognostic value of FDG PET\/CT during radiotherapy in head and neck cancer patients","volume":"36","author":"S Kim","year":"2018","journal-title":"Radiat Oncol J"},{"issue":"13","key":"pone.0341189.ref018","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00259-015-3104-8","article-title":"Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma","volume":"42","author":"M Min","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"pone.0341189.ref019","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MNM.0b013e3283334e2b","article-title":"Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?","volume":"31","author":"A Farrag","year":"2010","journal-title":"Nucl Med Commun"},{"issue":"7","key":"pone.0341189.ref020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"M Hentschel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0341189.ref021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.oraloncology.2018.11.005","article-title":"Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review","volume":"88","author":"RM Martens","year":"2019","journal-title":"Oral Oncol"},{"issue":"2","key":"pone.0341189.ref022","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00259-017-3836-8","article-title":"The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer","volume":"45","author":"K-R Kim","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"pone.0341189.ref023","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.18632\/oncotarget.3301","article-title":"Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of gene-expression data","volume":"6","author":"L De Cecco","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0341189.ref024","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pro6.1219","article-title":"Precision radiotherapy for nasopharyngeal carcinoma","volume":"8","author":"Z Zhang","year":"2024","journal-title":"Precis Radiat Oncol"},{"issue":"1","key":"pone.0341189.ref025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pro6.70007","article-title":"The evolution of prophylactic neck irradiation in nasopharyngeal carcinoma: changing concepts and irradiation ranges","volume":"9","author":"W Liao","year":"2025","journal-title":"Precis Radiat Oncol"},{"issue":"5","key":"pone.0341189.ref026","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clon.2019.12.004","article-title":"A review of modern radiation therapy dose escalation in locally advanced head and neck cancer","volume":"32","author":"D Atwell","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"pone.0341189.ref027","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2021.12.175","article-title":"Diffusion-weighted magnetic resonance imaging-guided dose painting in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus concurrent chemoradiotherapy: a randomized, controlled clinical trial","volume":"113","author":"S Fu","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"pone.0341189.ref028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124018","article-title":"A randomized pilot trial comparing position emission tomography (PET)-guided dose escalation radiotherapy to conventional radiotherapy in chemoradiotherapy treatment of locally advanced nasopharyngeal carcinoma","volume":"10","author":"J Wang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0341189.ref029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2010.01.026","article-title":"Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial","volume":"80","author":"RL Bakst","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"pone.0341189.ref030","first-page":"1059","article-title":"Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials","volume":"47","author":"LK Shankar","year":"2006","journal-title":"J Nucl Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:23:34Z","timestamp":1770315814000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341189"}},"subtitle":[],"editor":[{"given":"Carmelo","family":"Caldarella","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341189","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}